External Neuromodulation Market Report

Global External Neuromodulation Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 09, 2022
  • PAGES：224
  • REPORT CODE：GMM866588
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • External Neuromodulation market report explains the definition, types, applications, major countries, and major players of the External Neuromodulation market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Medtronic Inc (US)

    • BioControl Medical (Israel)

    • Cyberonics Inc (US)

    • Boston Scientific Corporation (US)

    • Synapse Biomedical Inc (US)

    • Nevro Corporation (US)

    • Neuronetics Inc (US)

    • Neurosigma Inc (US)

    • Neuropace Inc (US)

    • St Jude Medical Inc (US)

    By Type:

    • Transcutaneous Electrical Nerve Stimulation

    • Transcranial Magnetic Stimulation

    • Respiratory Electrical Stimulation

    By End-User:

    • Spinal Cord Stimulation

    • Deep Brain Stimulation

    • Sacral Nerve Stimulation

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global External Neuromodulation Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 External Neuromodulation Outlook to 2028- Original Forecasts

    • 2.2 External Neuromodulation Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term External Neuromodulation Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global External Neuromodulation Market- Recent Developments

    • 6.1 External Neuromodulation Market News and Developments

    • 6.2 External Neuromodulation Market Deals Landscape

    7 External Neuromodulation Raw Materials and Cost Structure Analysis

    • 7.1 External Neuromodulation Key Raw Materials

    • 7.2 External Neuromodulation Price Trend of Key Raw Materials

    • 7.3 External Neuromodulation Key Suppliers of Raw Materials

    • 7.4 External Neuromodulation Market Concentration Rate of Raw Materials

    • 7.5 External Neuromodulation Cost Structure Analysis

      • 7.5.1 External Neuromodulation Raw Materials Analysis

      • 7.5.2 External Neuromodulation Labor Cost Analysis

      • 7.5.3 External Neuromodulation Manufacturing Expenses Analysis

    8 Global External Neuromodulation Import and Export Analysis (Top 10 Countries)

    • 8.1 Global External Neuromodulation Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global External Neuromodulation Export by Region (Top 10 Countries) (2017-2028)

    9 Global External Neuromodulation Market Outlook by Types and Applications to 2022

    • 9.1 Global External Neuromodulation Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Transcutaneous Electrical Nerve Stimulation Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Transcranial Magnetic Stimulation Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Respiratory Electrical Stimulation Consumption and Growth Rate (2017-2022)

    • 9.2 Global External Neuromodulation Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Spinal Cord Stimulation Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Deep Brain Stimulation Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Sacral Nerve Stimulation Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise External Neuromodulation Market Analysis and Outlook till 2022

    • 10.1 Global External Neuromodulation Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States External Neuromodulation Consumption (2017-2022)

      • 10.2.2 Canada External Neuromodulation Consumption (2017-2022)

      • 10.2.3 Mexico External Neuromodulation Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany External Neuromodulation Consumption (2017-2022)

      • 10.3.2 UK External Neuromodulation Consumption (2017-2022)

      • 10.3.3 Spain External Neuromodulation Consumption (2017-2022)

      • 10.3.4 Belgium External Neuromodulation Consumption (2017-2022)

      • 10.3.5 France External Neuromodulation Consumption (2017-2022)

      • 10.3.6 Italy External Neuromodulation Consumption (2017-2022)

      • 10.3.7 Denmark External Neuromodulation Consumption (2017-2022)

      • 10.3.8 Finland External Neuromodulation Consumption (2017-2022)

      • 10.3.9 Norway External Neuromodulation Consumption (2017-2022)

      • 10.3.10 Sweden External Neuromodulation Consumption (2017-2022)

      • 10.3.11 Poland External Neuromodulation Consumption (2017-2022)

      • 10.3.12 Russia External Neuromodulation Consumption (2017-2022)

      • 10.3.13 Turkey External Neuromodulation Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China External Neuromodulation Consumption (2017-2022)

      • 10.4.2 Japan External Neuromodulation Consumption (2017-2022)

      • 10.4.3 India External Neuromodulation Consumption (2017-2022)

      • 10.4.4 South Korea External Neuromodulation Consumption (2017-2022)

      • 10.4.5 Pakistan External Neuromodulation Consumption (2017-2022)

      • 10.4.6 Bangladesh External Neuromodulation Consumption (2017-2022)

      • 10.4.7 Indonesia External Neuromodulation Consumption (2017-2022)

      • 10.4.8 Thailand External Neuromodulation Consumption (2017-2022)

      • 10.4.9 Singapore External Neuromodulation Consumption (2017-2022)

      • 10.4.10 Malaysia External Neuromodulation Consumption (2017-2022)

      • 10.4.11 Philippines External Neuromodulation Consumption (2017-2022)

      • 10.4.12 Vietnam External Neuromodulation Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil External Neuromodulation Consumption (2017-2022)

      • 10.5.2 Colombia External Neuromodulation Consumption (2017-2022)

      • 10.5.3 Chile External Neuromodulation Consumption (2017-2022)

      • 10.5.4 Argentina External Neuromodulation Consumption (2017-2022)

      • 10.5.5 Venezuela External Neuromodulation Consumption (2017-2022)

      • 10.5.6 Peru External Neuromodulation Consumption (2017-2022)

      • 10.5.7 Puerto Rico External Neuromodulation Consumption (2017-2022)

      • 10.5.8 Ecuador External Neuromodulation Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain External Neuromodulation Consumption (2017-2022)

      • 10.6.2 Kuwait External Neuromodulation Consumption (2017-2022)

      • 10.6.3 Oman External Neuromodulation Consumption (2017-2022)

      • 10.6.4 Qatar External Neuromodulation Consumption (2017-2022)

      • 10.6.5 Saudi Arabia External Neuromodulation Consumption (2017-2022)

      • 10.6.6 United Arab Emirates External Neuromodulation Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria External Neuromodulation Consumption (2017-2022)

      • 10.7.2 South Africa External Neuromodulation Consumption (2017-2022)

      • 10.7.3 Egypt External Neuromodulation Consumption (2017-2022)

      • 10.7.4 Algeria External Neuromodulation Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia External Neuromodulation Consumption (2017-2022)

      • 10.8.2 New Zealand External Neuromodulation Consumption (2017-2022)

    11 Global External Neuromodulation Competitive Analysis

    • 11.1 Medtronic Inc (US)

      • 11.1.1 Medtronic Inc (US) Company Details

      • 11.1.2 Medtronic Inc (US) External Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Medtronic Inc (US) External Neuromodulation Main Business and Markets Served

      • 11.1.4 Medtronic Inc (US) External Neuromodulation Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 BioControl Medical (Israel)

      • 11.2.1 BioControl Medical (Israel) Company Details

      • 11.2.2 BioControl Medical (Israel) External Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 BioControl Medical (Israel) External Neuromodulation Main Business and Markets Served

      • 11.2.4 BioControl Medical (Israel) External Neuromodulation Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Cyberonics Inc (US)

      • 11.3.1 Cyberonics Inc (US) Company Details

      • 11.3.2 Cyberonics Inc (US) External Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Cyberonics Inc (US) External Neuromodulation Main Business and Markets Served

      • 11.3.4 Cyberonics Inc (US) External Neuromodulation Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Boston Scientific Corporation (US)

      • 11.4.1 Boston Scientific Corporation (US) Company Details

      • 11.4.2 Boston Scientific Corporation (US) External Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Boston Scientific Corporation (US) External Neuromodulation Main Business and Markets Served

      • 11.4.4 Boston Scientific Corporation (US) External Neuromodulation Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Synapse Biomedical Inc (US)

      • 11.5.1 Synapse Biomedical Inc (US) Company Details

      • 11.5.2 Synapse Biomedical Inc (US) External Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Synapse Biomedical Inc (US) External Neuromodulation Main Business and Markets Served

      • 11.5.4 Synapse Biomedical Inc (US) External Neuromodulation Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Nevro Corporation (US)

      • 11.6.1 Nevro Corporation (US) Company Details

      • 11.6.2 Nevro Corporation (US) External Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Nevro Corporation (US) External Neuromodulation Main Business and Markets Served

      • 11.6.4 Nevro Corporation (US) External Neuromodulation Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Neuronetics Inc (US)

      • 11.7.1 Neuronetics Inc (US) Company Details

      • 11.7.2 Neuronetics Inc (US) External Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Neuronetics Inc (US) External Neuromodulation Main Business and Markets Served

      • 11.7.4 Neuronetics Inc (US) External Neuromodulation Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Neurosigma Inc (US)

      • 11.8.1 Neurosigma Inc (US) Company Details

      • 11.8.2 Neurosigma Inc (US) External Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Neurosigma Inc (US) External Neuromodulation Main Business and Markets Served

      • 11.8.4 Neurosigma Inc (US) External Neuromodulation Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Neuropace Inc (US)

      • 11.9.1 Neuropace Inc (US) Company Details

      • 11.9.2 Neuropace Inc (US) External Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Neuropace Inc (US) External Neuromodulation Main Business and Markets Served

      • 11.9.4 Neuropace Inc (US) External Neuromodulation Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 St Jude Medical Inc (US)

      • 11.10.1 St Jude Medical Inc (US) Company Details

      • 11.10.2 St Jude Medical Inc (US) External Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 St Jude Medical Inc (US) External Neuromodulation Main Business and Markets Served

      • 11.10.4 St Jude Medical Inc (US) External Neuromodulation Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global External Neuromodulation Market Outlook by Types and Applications to 2028

    • 12.1 Global External Neuromodulation Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Transcutaneous Electrical Nerve Stimulation Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Transcranial Magnetic Stimulation Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Respiratory Electrical Stimulation Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global External Neuromodulation Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Spinal Cord Stimulation Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Deep Brain Stimulation Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Sacral Nerve Stimulation Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise External Neuromodulation Market Analysis and Outlook to 2028

    • 13.1 Global External Neuromodulation Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States External Neuromodulation Consumption Forecast (2022-2028)

      • 13.2.2 Canada External Neuromodulation Consumption Forecast (2022-2028)

      • 13.2.3 Mexico External Neuromodulation Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany External Neuromodulation Consumption Forecast (2022-2028)

      • 13.3.2 UK External Neuromodulation Consumption Forecast (2022-2028)

      • 13.3.3 Spain External Neuromodulation Consumption Forecast (2022-2028)

      • 13.3.4 Belgium External Neuromodulation Consumption Forecast (2022-2028)

      • 13.3.5 France External Neuromodulation Consumption Forecast (2022-2028)

      • 13.3.6 Italy External Neuromodulation Consumption Forecast (2022-2028)

      • 13.3.7 Denmark External Neuromodulation Consumption Forecast (2022-2028)

      • 13.3.8 Finland External Neuromodulation Consumption Forecast (2022-2028)

      • 13.3.9 Norway External Neuromodulation Consumption Forecast (2022-2028)

      • 13.3.10 Sweden External Neuromodulation Consumption Forecast (2022-2028)

      • 13.3.11 Poland External Neuromodulation Consumption Forecast (2022-2028)

      • 13.3.12 Russia External Neuromodulation Consumption Forecast (2022-2028)

      • 13.3.13 Turkey External Neuromodulation Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China External Neuromodulation Consumption Forecast (2022-2028)

      • 13.4.2 Japan External Neuromodulation Consumption Forecast (2022-2028)

      • 13.4.3 India External Neuromodulation Consumption Forecast (2022-2028)

      • 13.4.4 South Korea External Neuromodulation Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan External Neuromodulation Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh External Neuromodulation Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia External Neuromodulation Consumption Forecast (2022-2028)

      • 13.4.8 Thailand External Neuromodulation Consumption Forecast (2022-2028)

      • 13.4.9 Singapore External Neuromodulation Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia External Neuromodulation Consumption Forecast (2022-2028)

      • 13.4.11 Philippines External Neuromodulation Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam External Neuromodulation Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil External Neuromodulation Consumption Forecast (2022-2028)

      • 13.5.2 Colombia External Neuromodulation Consumption Forecast (2022-2028)

      • 13.5.3 Chile External Neuromodulation Consumption Forecast (2022-2028)

      • 13.5.4 Argentina External Neuromodulation Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela External Neuromodulation Consumption Forecast (2022-2028)

      • 13.5.6 Peru External Neuromodulation Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico External Neuromodulation Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador External Neuromodulation Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain External Neuromodulation Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait External Neuromodulation Consumption Forecast (2022-2028)

      • 13.6.3 Oman External Neuromodulation Consumption Forecast (2022-2028)

      • 13.6.4 Qatar External Neuromodulation Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia External Neuromodulation Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates External Neuromodulation Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria External Neuromodulation Consumption Forecast (2022-2028)

      • 13.7.2 South Africa External Neuromodulation Consumption Forecast (2022-2028)

      • 13.7.3 Egypt External Neuromodulation Consumption Forecast (2022-2028)

      • 13.7.4 Algeria External Neuromodulation Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia External Neuromodulation Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand External Neuromodulation Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of External Neuromodulation

    • Figure of External Neuromodulation Picture

    • Table Global External Neuromodulation Import by Region (Top 10 Countries) (2017-2028)

    • Table Global External Neuromodulation Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Transcutaneous Electrical Nerve Stimulation Consumption and Growth Rate (2017-2022)

    • Figure Global Transcranial Magnetic Stimulation Consumption and Growth Rate (2017-2022)

    • Figure Global Respiratory Electrical Stimulation Consumption and Growth Rate (2017-2022)

    • Figure Global Spinal Cord Stimulation Consumption and Growth Rate (2017-2022)

    • Figure Global Deep Brain Stimulation Consumption and Growth Rate (2017-2022)

    • Figure Global Sacral Nerve Stimulation Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global External Neuromodulation Consumption by Country (2017-2022)

    • Table North America External Neuromodulation Consumption by Country (2017-2022)

    • Figure United States External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Canada External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Mexico External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Table Europe External Neuromodulation Consumption by Country (2017-2022)

    • Figure Germany External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure UK External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Spain External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Belgium External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure France External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Italy External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Denmark External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Finland External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Norway External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Sweden External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Poland External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Russia External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Turkey External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Table APAC External Neuromodulation Consumption by Country (2017-2022)

    • Figure China External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Japan External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure India External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure South Korea External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Pakistan External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Indonesia External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Thailand External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Singapore External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Malaysia External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Philippines External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Vietnam External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Table South America External Neuromodulation Consumption by Country (2017-2022)

    • Figure Brazil External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Colombia External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Chile External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Argentina External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Venezuela External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Peru External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Ecuador External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Table GCC External Neuromodulation Consumption by Country (2017-2022)

    • Figure Bahrain External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Kuwait External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Oman External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Qatar External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Table Africa External Neuromodulation Consumption by Country (2017-2022)

    • Figure Nigeria External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure South Africa External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Egypt External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Algeria External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Table Oceania External Neuromodulation Consumption by Country (2017-2022)

    • Figure Australia External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure New Zealand External Neuromodulation Consumption and Growth Rate (2017-2022)

    • Table Medtronic Inc (US) Company Details

    • Table Medtronic Inc (US) External Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic Inc (US) External Neuromodulation Main Business and Markets Served

    • Table Medtronic Inc (US) External Neuromodulation Product Portfolio

    • Table BioControl Medical (Israel) Company Details

    • Table BioControl Medical (Israel) External Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioControl Medical (Israel) External Neuromodulation Main Business and Markets Served

    • Table BioControl Medical (Israel) External Neuromodulation Product Portfolio

    • Table Cyberonics Inc (US) Company Details

    • Table Cyberonics Inc (US) External Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cyberonics Inc (US) External Neuromodulation Main Business and Markets Served

    • Table Cyberonics Inc (US) External Neuromodulation Product Portfolio

    • Table Boston Scientific Corporation (US) Company Details

    • Table Boston Scientific Corporation (US) External Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boston Scientific Corporation (US) External Neuromodulation Main Business and Markets Served

    • Table Boston Scientific Corporation (US) External Neuromodulation Product Portfolio

    • Table Synapse Biomedical Inc (US) Company Details

    • Table Synapse Biomedical Inc (US) External Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

    • Table Synapse Biomedical Inc (US) External Neuromodulation Main Business and Markets Served

    • Table Synapse Biomedical Inc (US) External Neuromodulation Product Portfolio

    • Table Nevro Corporation (US) Company Details

    • Table Nevro Corporation (US) External Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nevro Corporation (US) External Neuromodulation Main Business and Markets Served

    • Table Nevro Corporation (US) External Neuromodulation Product Portfolio

    • Table Neuronetics Inc (US) Company Details

    • Table Neuronetics Inc (US) External Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neuronetics Inc (US) External Neuromodulation Main Business and Markets Served

    • Table Neuronetics Inc (US) External Neuromodulation Product Portfolio

    • Table Neurosigma Inc (US) Company Details

    • Table Neurosigma Inc (US) External Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neurosigma Inc (US) External Neuromodulation Main Business and Markets Served

    • Table Neurosigma Inc (US) External Neuromodulation Product Portfolio

    • Table Neuropace Inc (US) Company Details

    • Table Neuropace Inc (US) External Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neuropace Inc (US) External Neuromodulation Main Business and Markets Served

    • Table Neuropace Inc (US) External Neuromodulation Product Portfolio

    • Table St Jude Medical Inc (US) Company Details

    • Table St Jude Medical Inc (US) External Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

    • Table St Jude Medical Inc (US) External Neuromodulation Main Business and Markets Served

    • Table St Jude Medical Inc (US) External Neuromodulation Product Portfolio

    • Figure Global Transcutaneous Electrical Nerve Stimulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Transcranial Magnetic Stimulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Respiratory Electrical Stimulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Spinal Cord Stimulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Deep Brain Stimulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sacral Nerve Stimulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global External Neuromodulation Consumption Forecast by Country (2022-2028)

    • Table North America External Neuromodulation Consumption Forecast by Country (2022-2028)

    • Figure United States External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe External Neuromodulation Consumption Forecast by Country (2022-2028)

    • Figure Germany External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure France External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC External Neuromodulation Consumption Forecast by Country (2022-2028)

    • Figure China External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure India External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Table South America External Neuromodulation Consumption Forecast by Country (2022-2028)

    • Figure Brazil External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC External Neuromodulation Consumption Forecast by Country (2022-2028)

    • Figure Bahrain External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa External Neuromodulation Consumption Forecast by Country (2022-2028)

    • Figure Nigeria External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania External Neuromodulation Consumption Forecast by Country (2022-2028)

    • Figure Australia External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand External Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US